Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study

[1]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[2]  M. Páez de la Cadena,et al.  Proteomics for discovery of candidate colorectal cancer biomarkers. , 2014, World journal of gastroenterology.

[3]  J. Yun,et al.  Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients , 2013, Proteomics.

[4]  H. Friess,et al.  iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance , 2013, British Journal of Cancer.

[5]  G. Meijer,et al.  Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. , 2013, Clinical biochemistry.

[6]  Paolo Vineis,et al.  Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research , 2013, Environmental health perspectives.

[7]  Fabio Grizzi,et al.  Prognostic value of innate and adaptive immunity in colorectal cancer. , 2013, World journal of gastroenterology.

[8]  C. McCulloch,et al.  Multifunctional roles of gelsolin in health and diseases , 2012, Medicinal research reviews.

[9]  H. Tjalsma,et al.  Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer , 2012, Biological reviews of the Cambridge Philosophical Society.

[10]  S. Gammeltoft,et al.  Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer , 2012, Proteomics. Clinical applications.

[11]  S. Tsugane,et al.  Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia , 2012, International Journal of Obesity.

[12]  S. Hanash,et al.  Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women , 2012, Cancer Prevention Research.

[13]  M. P. Cadena,et al.  Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer , 2012, Cancer Investigation.

[14]  R. Dziarski,et al.  Peptidoglycan recognition proteins: modulators of the microbiome and inflammation , 2011, Nature Reviews Immunology.

[15]  N. Sata,et al.  Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray , 2011, Cancer science.

[16]  P. Brigidi,et al.  Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer , 2011, Critical reviews in microbiology.

[17]  Takahiro Tanaka,et al.  Biomarkers for Colorectal Cancer , 2010, International journal of molecular sciences.

[18]  F. Clavel-Chapelon,et al.  Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. , 2010, American journal of epidemiology.

[19]  M. Loh,et al.  ITIH3 is a potential biomarker for early detection of gastric cancer. , 2010, Journal of proteome research.

[20]  F. Clavel-Chapelon,et al.  Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study , 2010, BMJ : British Medical Journal.

[21]  Francesco Rulli,et al.  Clusterin in Stool: A New Biomarker for Colon Cancer Screening? , 2009, The American Journal of Gastroenterology.

[22]  Manuela Truebano,et al.  The consequences of sample pooling in proteomics: An empirical study , 2009, Electrophoresis.

[23]  Yanlei Ma,et al.  Searching for serum tumor markers for colorectal cancer using a 2‐D DIGE approach , 2009, Electrophoresis.

[24]  John D Lambris,et al.  Is complement good or bad for cancer patients? A new perspective on an old dilemma. , 2009, Trends in immunology.

[25]  J. O’Sullivan,et al.  High Clusterin Expression Correlates with a Poor Outcome in Stage II Colorectal Cancers , 2009, Cancer Epidemiology Biomarkers & Prevention.

[26]  E. Feener,et al.  Label-free Quantitative Analysis of One-dimensional PAGE LC/MS/MS Proteome , 2008, Molecular & Cellular Proteomics.

[27]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[28]  N Leigh Anderson,et al.  High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.

[29]  Ovidiu Daescu,et al.  The Human Red Blood Cell Proteome and Interactome , 2007, Experimental biology and medicine.

[30]  M. Gleave,et al.  Differential Regulation of Clusterin and Its Isoforms by Androgens in Prostate Cells* , 2007, Journal of Biological Chemistry.

[31]  F. J. Rodríguez-Berrocal,et al.  Differential Expression of Serum Clusterin Isoforms in Colorectal Cancer* , 2006, Molecular & Cellular Proteomics.

[32]  Jos H Beijnen,et al.  Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. , 2006, World journal of gastroenterology.

[33]  Eduardo Esteve,et al.  Dyslipidemia and inflammation: an evolutionary conserved mechanism. , 2005, Clinical nutrition.

[34]  A. Blom,et al.  Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? , 2004, Molecular immunology.

[35]  Paolo Vineis,et al.  A Molecular Epidemiology Project on Diet and Cancer: The Epic-Italy Prospective Study. Design and Baseline Characteristics of Participants , 2003, Tumori.

[36]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[37]  I. Trougakos,et al.  Clusterin/apolipoprotein J in human aging and cancer. , 2002, The international journal of biochemistry & cell biology.

[38]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[39]  G. Nelsestuen,et al.  Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization. , 1997, Biochemistry.

[40]  Elio Riboli,et al.  The EPIC Project: Rationale and study design , 1997 .

[41]  J. Faivre,et al.  [Primary prevention of colorectal cancer]. , 1995, Bulletin du cancer.

[42]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[43]  J. Tschopp,et al.  Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Moon,et al.  Influence of gonadal hormones and age on 1,2‐ dimethylhydrazine‐induced colon carcinogenesis , 1977, Cancer.

[45]  Kathryn S Lilley,et al.  Investigating sample pooling strategies for DIGE experiments to address biological variability , 2009, Proteomics.

[46]  S. Pucci,et al.  CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype. , 2009, Advances in cancer research.

[47]  G. Chiocchia,et al.  Clusterin : A Multifacet Protein at the Crossroad of Inflammation and Autoimmunity , 2009 .

[48]  J. Willis,et al.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer , 2006, Cell Death and Differentiation.

[49]  Stefano Iacobelli,et al.  90K (Mac-2 BP) and galectins in tumor progression and metastasis , 2004, Glycoconjugate Journal.

[50]  C. Jomary,et al.  Clusterin , 2019, Springer Reference Medizin.

[51]  E Riboli,et al.  The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[52]  P. Pietinen,et al.  European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. , 1997, International journal of epidemiology.

[53]  A. Kuryliszyn-Moskal,et al.  Alpha 1-antitrypsin and alpha 1-antichymotrypsin serum level in relation to staging and postoperative clinical course of human colorectal cancer. , 1988, Advances in experimental medicine and biology.